We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSMX
2201
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$5K ﹤0.01%
744
+300
+68% +$2K
EXTN
2202
DELISTED
Exterran Corporation
EXTN
$5K ﹤0.01%
699
– –
BGG
2203
DELISTED
Briggs & Stratton Corp.
BGG
$5K ﹤0.01%
779
– –
KNL
2204
DELISTED
Knoll, Inc.
KNL
$5K ﹤0.01%
211
+133
+171% +$3.51K
STL
2205
DELISTED
Sterling Bancorp
STL
$5K ﹤0.01%
281
+28
+11% +$571
ADTN icon
2206
Adtran
ADTN
$730M
$4K ﹤0.01%
469
-114
-20% -$1.09K
ATI icon
2207
ATI
ATI
$25.5B
$4K ﹤0.01%
238
+110
+86% +$2.38K
ATNI icon
2208
ATN International
ATNI
$370M
$4K ﹤0.01%
89
– –
BKU icon
2209
Bankunited
BKU
$3.41B
$4K ﹤0.01%
+112
New +$3.9K
BLUE
2210
DELISTED
bluebird bio
BLUE
$4K ﹤0.01%
4
– –
BOOM icon
2211
DMC Global
BOOM
$112M
$4K ﹤0.01%
105
+25
+31% +$1.11K
CRVL icon
2212
CorVel
CRVL
$3.14B
$4K ﹤0.01%
141
– –
CSPI icon
2213
CSP Inc
CSPI
$81.9M
$4K ﹤0.01%
666
– –
CX icon
2214
Cemex
CX
$17.3B
$4K ﹤0.01%
1,254
+435
+53% +$1.66K
CYTK icon
2215
Cytokinetics
CYTK
$10.8B
$4K ﹤0.01%
435
-173
-28% -$1.78K
DBJP icon
2216
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$680M
$4K ﹤0.01%
113
– –
DENN
2217
DELISTED
Denny's
DENN
$4K ﹤0.01%
218
-8
-4% -$165
EMBJ
2218
Embraer S.A. ADS
EMBJ
$12.3B
$4K ﹤0.01%
233
+74
+47% +$1.3K
FIBK icon
2219
First Interstate BancSystem
FIBK
$3.7B
$4K ﹤0.01%
105
– –
GPRE icon
2220
Green Plains
GPRE
$1.15B
$4K ﹤0.01%
288
– –
GRFS
2221
Grifois
GRFS
$5.44B
$4K ﹤0.01%
192
+174
+967% +$3.79K
H icon
2222
Hyatt Hotels
H
$17.8B
$4K ﹤0.01%
45
– –
HTBK
2223
DELISTED
Heritage Commerce
HTBK
$4K ﹤0.01%
373
– –
MKTX icon
2224
MarketAxess Holdings
MKTX
$4.34B
$4K ﹤0.01%
13
+9
+225% +$3.3K
PCG icon
2225
PG&E
PCG
$39.2B
$4K ﹤0.01%
400
-650
-62% -$5.57K
87 88
89
90 91

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.